Literature DB >> 9151798

Leukocyte adhesion in angiogenic blood vessels. Role of E-selectin, P-selectin, and beta2 integrin in lymphotoxin-mediated leukocyte recruitment in tumor microvessels.

P Borgström1, G K Hughes, P Hansell, B A Wolitsky, P Sriramarao.   

Abstract

Interaction of circulating leukocytes with tumor microvasculature is a critical event in the recruitment of effector cells into the tumor stroma. We have examined the ability of lymphotoxin (TNF-beta), to stimulate rolling, adhesion, and transmigration of leukocytes in angiogenic blood vessels induced by tumor spheroids of Lewis lung carcinoma (LLC) implanted in dorsal skinfold chambers of nude mice. In the absence of cytokine stimulation, circulating leukocytes failed to appreciably interact with tumor microvessels (TMV), although significant rolling and adhesion was observed in normal vessels. However, stimulation with lymphotoxin (LT) resulted in a rapid increase in the number of fast and slow rolling leukocytes in TMV. Treatment with anti-P-selectin mAb 5H1 resulted in inhibition of fast rollers alone, while combination treatment with anti-P-selectin and anti-E-selectin (9A9) mAbs effectively blocked slow rolling of leukocytes. Superfusion of the lymphotoxin-stimulated neovasculature with leukotriene B4 (LTB4) resulted in stable cell adhesion followed by emigration of leukocytes into the tumor stroma. LTB4-mediated adhesion and transmigration was significantly inhibited by treatment with anti-beta2 mAb 2E6. These studies delineate a multistep cascade of leukocyte adhesion in TMV and demonstrate that stimulation of the neovasculature with cytokines and chemoattractants can result in P- and E-selectin-dependent rolling and beta2-dependent stable adhesion followed by transmigration into the tumor stroma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9151798      PMCID: PMC508056          DOI: 10.1172/JCI119399

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Quantitative angiogenesis in a syngeneic tumor spheroid model.

Authors:  I P Torres Filho; B Hartley-Asp; P Borgström
Journal:  Microvasc Res       Date:  1995-03       Impact factor: 3.514

2.  Suppression of tumor growth in vivo by local and systemic 90K level increase.

Authors:  B Jallal; J Powell; J Zachwieja; C Brakebusch; L Germain; J Jacobs; S Iacobelli; A Ullrich
Journal:  Cancer Res       Date:  1995-08-01       Impact factor: 12.701

3.  Characterization of E-selectin-deficient mice: demonstration of overlapping function of the endothelial selectins.

Authors:  M A Labow; C R Norton; J M Rumberger; K M Lombard-Gillooly; D J Shuster; J Hubbard; R Bertko; P A Knaack; R W Terry; M L Harbison
Journal:  Immunity       Date:  1994-11       Impact factor: 31.745

4.  Expression of platelet-endothelial cell adhesion molecule-1 (PECAM-1) during melanoma-induced angiogenesis in vivo.

Authors:  R Berger; S M Albelda; D Berd; M Ioffreda; D Whitaker; G F Murphy
Journal:  J Cutan Pathol       Date:  1993-10       Impact factor: 1.587

5.  Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.

Authors:  D L Gibbons; M Rowe; A P Cope; M Feldmann; F M Brennan
Journal:  Eur J Immunol       Date:  1994-08       Impact factor: 5.532

6.  Tumor growth inhibition mediated by lymphotoxin: evidence of B lymphocyte involvement in the antitumor response.

Authors:  Z Qin; T Blankenstein
Journal:  Cancer Res       Date:  1995-11-01       Impact factor: 12.701

7.  alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow.

Authors:  C Berlin; R F Bargatze; J J Campbell; U H von Andrian; M C Szabo; S R Hasslen; R D Nelson; E L Berg; S L Erlandsen; E C Butcher
Journal:  Cell       Date:  1995-02-10       Impact factor: 41.582

8.  Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice.

Authors:  Z Qin; L J van Tits; W A Buurman; T Blankenstein
Journal:  Blood       Date:  1995-05-15       Impact factor: 22.113

9.  Leukocyte rolling in venules of striated muscle and skin is mediated by P-selectin, not by L-selectin.

Authors:  D Nolte; P Schmid; U Jäger; A Botzlar; F Roesken; R Hecht; E Uhl; K Messmer; D Vestweber
Journal:  Am J Physiol       Date:  1994-10

10.  Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma.

Authors:  L Piali; A Fichtel; H J Terpe; B A Imhof; R H Gisler
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Involvement of eicosanoids in the pathogenesis of pancreatic cancer: the roles of cyclooxygenase-2 and 5-lipoxygenase.

Authors:  Lawrence M Knab; Paul J Grippo; David J Bentrem
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression.

Authors:  Sandra I Zittermann; Andrew C Issekutz
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

3.  Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study.

Authors:  Takeshi Hatanaka; Satoru Kakizaki; Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Ochi; Satoshi Yasuda; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Noritomo Shimada; Kazuhito Kawata; Hisashi Kosaka; Takaaki Tanaka; Hideko Ohama; Kazuhiro Nouso; Asahiro Morishita; Akemi Tsutsui; Takuya Nagano; Norio Itokawa; Tomomi Okubo; Taeang Arai; Michitaka Imai; Atsushi Naganuma; Yohei Koizumi; Shinichiro Nakamura; Kouji Joko; Masaki Kaibori; Hiroko Iijima; Yoichi Hiasa; Takashi Kumada
Journal:  Hepatol Int       Date:  2022-06-24       Impact factor: 9.029

4.  Exposure to environmental tobacco smoke induces angiogenesis and leukocyte trafficking in lung microvessels.

Authors:  Savita P Rao; Lyudmila Sikora; M Reza Hosseinkhani; Kent E Pinkerton; P Sriramarao
Journal:  Exp Lung Res       Date:  2009-03       Impact factor: 2.459

5.  A murine model to study leukocyte rolling and intravascular trafficking in lung microvessels.

Authors:  Lyudmila Sikora; Asa C M Johansson; Savita P Rao; Greg K Hughes; David H Broide; P Sriramarao
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

6.  Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits.

Authors:  Patrick M Winter; Anne H Schmieder; Shelton D Caruthers; Jeffery L Keene; Huiying Zhang; Samuel A Wickline; Gregory M Lanza
Journal:  FASEB J       Date:  2008-03-24       Impact factor: 5.191

7.  Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668.

Authors:  Hong Zhang; Andrew C Issekutz
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

8.  Leukocyte-endothelial cell interactions are linked to vascular permeability via ICAM-1-mediated signaling.

Authors:  Ronen Sumagin; Elena Lomakina; Ingrid H Sarelius
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-18       Impact factor: 4.733

9.  Bevacizumab plus ipilimumab in patients with metastatic melanoma.

Authors:  F Stephen Hodi; Donald Lawrence; Cecilia Lezcano; Xinqi Wu; Jun Zhou; Tetsuro Sasada; Wanyong Zeng; Anita Giobbie-Hurder; Michael B Atkins; Nageatte Ibrahim; Philip Friedlander; Keith T Flaherty; George F Murphy; Scott Rodig; Elsa F Velazquez; Martin C Mihm; Sara Russell; Pamela J DiPiro; Jeffrey T Yap; Nikhil Ramaiya; Annick D Van den Abbeele; Maria Gargano; David McDermott
Journal:  Cancer Immunol Res       Date:  2014-04-21       Impact factor: 11.151

10.  Suppression of tumor growth and angiogenesis in vivo by a truncated form of 24-kd fibroblast growth factor (FGF)-2.

Authors:  Eugene G Levin; Lyudmila Sikora; Lan Ding; Savita P Rao; P Sriramarao
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.